Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial

Chiung-Jung Jo Wu1,2,3,4, John J Atherton5,6, Richard J MacIsaac7,8,9

  • 1School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Australian Catholic University, 1100 Nudgee Rd, Banyo, Qld, 4014, Australia. c3.wu@qut.edu.au.

Insights

This study evaluates a Cardiac-Diabetes Transcare program for patients with acute coronary syndrome and type 2 diabetes. The intervention aims to reduce hospital readmissions through enhanced self-management support.

Area of Science:

  • Cardiology
  • Endocrinology
  • Health Services Research

Background:

  • Patients with acute coronary syndrome (ACS) and type 2 diabetes (T2D) face elevated risks of hospital readmission, morbidity, and mortality.
  • Transitional care programs are crucial for managing complex chronic conditions.
  • The Cardiac-Diabetes Transcare program is a multi-modal self-management intervention designed for this high-risk population.

Purpose of the Study:

  • To evaluate the effectiveness and cost-effectiveness of the Cardiac-Diabetes Transcare program.
  • To determine if the intervention can reduce the 6-month hospital readmission rate compared to usual care.
  • To assess the impact of the program on patient self-efficacy and self-management behaviors.

Main Methods:

  • A two-armed, randomised controlled trial (RCT) with blinded outcome assessment.
  • Participants will be randomized to either a Usual Care Group or the Cardiac-Diabetes Transcare Intervention Group.
  • The intervention includes in-hospital education, home visits, and telephone follow-up by a Research Nurse.

Main Results:

  • The primary outcome is the 6-month readmission rate.
  • Secondary outcomes, including self-efficacy, will be assessed at baseline and at 1, 3, and 6 months.
  • A sample size of 432 participants will be recruited from hospitals in Queensland and Victoria, Australia.

Conclusions:

  • The study protocol outlines a rigorous RCT to investigate a targeted transitional care intervention.
  • Findings are expected to provide valuable insights into improving health outcomes for patients with comorbid ACS and T2D.
  • The intervention's potential to enhance self-efficacy and reduce hospital readmissions will be elucidated.
Abstract